Video
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some of the DEA's requirements for handling controlled substances.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some of the DEA's requirements for handling controlled substances.
This video was recorded at the National Community Pharmacists Association's (NCPA) 2015 Annual Convention.
FDA Grants Approval to Generic Extended-Release Memantine/Donepezil and Everolimus